No­var­tis signs off on $20B deal to sell Roche stake, ac­quired 20 years ago, back to cross-town ri­val

For the past 20 years, No­var­tis and Roche were more than cross-town ri­vals reign­ing over tow­er­ing phar­ma­ceu­ti­cal dy­nas­ties. No­var­tis al­so holds a siz­able chunk of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER